Drug & intervention

macitentan

RxCUI 1442132

Clinical trials20
Recruiting1
Related conditions8
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

20 shown
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other OptionNCT05179876 · 2022-05-04
RECRUITING
A Study of Macitentan in Children Below 2 Years of AgeNCT05731492 · 2024-03-14
WITHDRAWN
A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial HypertensionNCT05167825 · 2022-11-14
COMPLETED
A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary HypertensionNCT04271475 · 2020-07-07
TERMINATED
A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.NCT03422328 · 2018-04-05
COMPLETED
A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)NCT02932410 · 2017-10-24
COMPLETED
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular DiseaseNCT03153111 · 2017-07-11
COMPLETED
The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial HypertensionNCT02558231 · 2016-05-01
COMPLETED
Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)NCT02968901 · 2015-09-01
TERMINATED
Macitentan in Pulmonary Hypertension of Sickle Cell DiseaseNCT02651272 · 2015-07-01
TERMINATED
PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical TrialNCT02382016 · 2015-06-23
COMPLETED
REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtensionNCT02310672 · 2015-06-01
COMPLETED
Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary HypertensionNCT02060721 · 2015-02-03
COMPLETED
Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary HypertensionNCT02021292 · 2014-08-20
COMPLETED
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular DysfunctionNCT02070991 · 2014-07-01
COMPLETED
Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAHNCT02112487 · 2014-06-23
COMPLETED
A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT™ in France, Italy and SpainNCT02081690 · 2014-03-01
TERMINATED
Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT InstrumentNCT01847014 · 2013-09-01
TERMINATED
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT InstrumentNCT01841762 · 2013-04-01
COMPLETED
Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial HypertensionNCT00667823 · 2008-10-17
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.